GTXI

GTx, Inc. Competitors

$1.18
*  
0.04
3.51%
Get GTXI Alerts
*Delayed - data as of May 28, 2015  -  Find a broker to begin trading GTXI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GTXI Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

GTx, Inc.

CompanyName
Symbol: Market
LastSale NetChange ▼ Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Actavis, Inc.
ACT: NYSE
$ 313.08 6.29 ▲ 3,942,951 $ 315
$ 308.41
$ 317.72
$ 201.91
NE 122,866,680,600
Galapagos NV
GLPG: NASDAQ-GS
$ 54 4.09 ▲ 102,703 $ 54.45
$ 51.9274
$ 54.86
$ 44.10
NE 1,921,914,000
Sage Therapeutics, Inc.
SAGE: NASDAQ-GM
$ 73.13 3.49 ▲ 474,011 $ 73.44
$ 67.43
$ 73.91
$ 24.25
NE 2,074,478,710
Valeant Pharmaceuticals International, Inc.
VRX: NYSE
$ 241.73 2.61 ▲ 2,645,687 $ 246.01
$ 238.12
$ 239.16
$ 106
81.94 82,787,448,670
Mirati Therapeutics, Inc.
MRTX: NASDAQ-CM
$ 36.18 2.43 ▲ 316,526 $ 36.89
$ 32.79
$ 34
$ 13.69
NE 584,813,520
Pacira Pharmaceuticals, Inc.
PCRX: NASDAQ-GS
$ 80.08 1.92 ▲ 822,469 $ 80.83
$ 77.95
$ 121.95
$ 65
NE 2,901,778,880
AMAG Pharmaceuticals, Inc.
AMAG: NASDAQ-GS
$ 68.52 1.83 ▲ 1,042,741 $ 68.72
$ 63.54
$ 68.23
$ 17.52
13.57 2,034,221,760
Shire plc
SHPG: NASDAQ-GS
$ 259.82 1.72 ▲ 608,008 $ 260.74
$ 257.82
$ 264.98
$ 156.25
14.28 51,989,462,360
Eli Lilly and Company
LLY: NYSE
$ 76.41 1.51 ▲ 4,819,838 $ 76.48
$ 74.74
$ 77.46
$ 58.50
37.27 84,795,309,810
BioSpecifics Technologies Corp
BSTC: NASDAQ-GM
$ 46.82 1.47 ▲ 139,822 $ 47.90
$ 44.4308
$ 45.50
$ 25
53.82 304,376,820
uniQure N.V.
QURE: NASDAQ-GS
$ 29.18 1.41 ▲ 438,662 $ 30.7587
$ 27.55
$ 35.50
$ 8.31
NE 537,758,220
Ultragenyx Pharmaceutical Inc.
RARE: NASDAQ-GS
$ 88.06 1.32 ▲ 300,795 $ 88.27
$ 84.28
$ 88.23
$ 32.36
NE 3,076,376,100
Cyclacel Pharmaceuticals, Inc.
CYCCP: NASDAQ-CM
$ 7.77 1.27 ▲ 2,149 $ 7.77
$ 7.08
$ 8.62
$ 3.50
NE 2,602,950
Akorn, Inc.
AKRX: NASDAQ-GS
$ 45.20 1.24 ▲ 1,507,605 $ 45.30
$ 43.57
$ 57.10
$ 27.09
136.97 4,873,961,200
Blueprint Medicines Corporation
BPMC: NASDAQ-GS
$ 28.55 1.21 ▲ 155,235 $ 29.26
$ 26.90
$ 32.8144
$ 18
NE 710,152,700
Eagle Pharmaceuticals, Inc.
EGRX: NASDAQ-GM
$ 68.91 1.19 ▲ 334,483 $ 70.662
$ 65.2601
$ 68.20
$ 10.06
1148.5 1,070,792,490
Portola Pharmaceuticals, Inc.
PTLA: NASDAQ-GS
$ 42.09 1.02 ▲ 692,707 $ 42.46
$ 39.71
$ 43.63
$ 20.236
NE 2,046,415,800
Recro Pharma, Inc.
REPH: NASDAQ-CM
$ 8.53 0.98 ▲ 73,868 $ 8.54
$ 7.33
$ 15.4014
$ 2.36
NE 66,892,260
Agios Pharmaceuticals, Inc.
AGIO: NASDAQ-GS
$ 124.20 0.97 ▲ 477,972 $ 124.60
$ 120.47
$ 138.85
$ 32.66
NE 4,622,475,600
Five Prime Therapeutics, Inc.
FPRX: NASDAQ-GS
$ 23.52 0.89 ▲ 348,330 $ 23.87
$ 21.87
$ 28.47
$ 10.50
NE 589,011,360
Ligand Pharmaceuticals Incorporated
LGND: NASDAQ-GM
$ 88.15 0.89 ▲ 340,376 $ 88.26
$ 84.56
$ 90.48
$ 41.99
172.84 1,725,800,700
Ophthotech Corporation
OPHT: NASDAQ-GS
$ 49.14 0.89 ▲ 393,252 $ 49.46
$ 46.72
$ 58.29
$ 35.38
NE 1,653,610,140
Xenon Pharmaceuticals Inc.
XENE: NASDAQ-GM
$ 13.15 0.79 ▲ 212,991 $ 13.49
$ 12.25
$ 23.50
$ 9.21
NE 187,111,350
MYOS Corporation
MYOS: NASDAQ-CM
$ 4.50 0.78 ▲ 84,554 $ 5.01
$ 3.7501
$ 16.85
$ 3.05
NE 14,004,000
Advaxis, Inc.
ADXSW: NASDAQ-CM
$ 18.25 0.75 ▲ 23,295 $ 18.78
$ 17.15
$ 19.52
$ .7625
NE 82,873,250